INTERIM RESULTS OF A PHASE 2 STUDY OF XMAB®5871, A REVERSIBLE B CELL INHIBITOR, IN IGG4-RELATED DISEASE

被引：3
|
作者：
Stone, J. H. [1 ]
Wallace, Z. S. [1 ]
Perugino, C. A. [1 ]
Fernandes, A. D. [1 ]
Patel, P. S. [1 ]
Foster, P. A. [2 ]
Zack, D. J. [2 ]
机构：
[1] Harvard, Massachusetts Gen Hosp, Rheumatol Unit, Boston, MA USA
[2] Xencor Inc, Clin Dev, Monrovia, CA USA
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2017年 / 76卷
关键词：
D O I：
10.1136/annrheumdis-2017-eular.3301
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
FRI0588
引用
收藏
页码：711 / 712
页数：2
相关论文
共 50 条
  • [1] A Trial of XmAb®5871, a Reversible Inhibitor of CD19+Cells, in IgG4-Related Disease
    Stone, John H.
    Wallace, Zachary S.
    Perugino, Cory A.
    Fernandes, Ana D.
    Foster, Paul A.
    Zack, Debra J.
    [J]. ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [2] PHASE 2, DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED STUDY OF A REVERSIBLE B CELL INHIBITOR, XMAB®5871, IN SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)
    Merrill, Joan
    June, Joshua
    Koumpouras, Fotios
    Machua, Wambui
    Khan, Mohammad Faisal
    Askanase, Anca
    Khosroshahi, Arezou
    Sheikh, Saira
    James, Judith A.
    Guthridge, Joel
    Rathi, Gaurav
    Burington, Bart
    Foster, Paul
    Zack, Debra
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 761 - 762
  • [3] B-cell depletion with obinutuzumab for the treatment of IgG4-related disease
    Lanzillotta, Marco
    Mapelli, Paola
    Dagna, Lorenzo
    Della-Torre, Emanuel
    [J]. EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2023, 116 : 155 - 156
  • [4] Results of a Phase 1b/2a Study of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of XmAb®5871 in Patients with Rheumatoid Arthritis (RA)
    Zack, Debra
    Baumann, Maria Jaraczewska
    Korkosz, Mariusz
    Suljok, Gabriella
    Sramek, Petr
    Rojkovich, Bernadette
    Daniluk, Stafan
    Bartalos, Janos
    Foster, Paul
    [J]. ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [5] A clinicopathological study on IgG4-related ophthalmic disease
    Yuka Suimon
    Satoru Kase
    Kan Ishijima
    Hiromi Kanno-Okada
    Susumu Ishida
    [J]. International Journal of Ophthalmology, 2018, (09) : 1539 - 1544
  • [6] A clinicopathological study on IgG4-related ophthalmic disease
    Suimon, Yuka
    Kase, Satoru
    Ishijima, Kan
    Kanno-Okada, Hiromi
    Ishida, Susumu
    [J]. INTERNATIONAL JOURNAL OF OPHTHALMOLOGY, 2018, 11 (09) : 1539 - 1544
  • [7] A case of IgG4-related disease associated with diffuse large B cell lymphoma
    Mitsuyama T.
    Nishio A.
    Takaoka M.
    Uchida K.
    Shimatani M.
    Fukui T.
    Ikeura T.
    Koyabu M.
    Miyoshi H.
    Kusuda T.
    Kurishima A.
    Fukui Y.
    Sumimoto K.
    Fujita S.
    Uemura Y.
    Okazaki K.
    [J]. Clinical Journal of Gastroenterology, 2013, 6 (1) : 63 - 68
  • [8] Effects of glucocorticoids on B-cell subpopulations in patients with IgG4-related disease
    Lanzillotta, M.
    Della-Torre, E.
    Milani, R.
    Bozzolo, E.
    Bozzalla-Cassione, B.
    Rovati, L.
    Arcidiacono, P. G.
    Partelli, S.
    Falconi, M.
    Ciceri, F.
    Dagna, L.
    [J]. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2019, 37 (03) : S159 - S166
  • [9] Peripheral B-Cell Immunophenotyping Identifies Heterogeneity in IgG4-Related Disease
    Li, Jieqiong
    Liu, Zheng
    Zhang, Panpan
    Lin, Wei
    Lu, Hui
    Peng, Yu
    Peng, Linyi
    Zhou, Jiaxin
    Wang, Mu
    Chen, Hua
    Zhao, Lidan
    Wang, Li
    Qin, Chenman
    Hu, Chaojun
    Zeng, Xiaofeng
    Zhao, Yan
    Fei, Yunyun
    Zhang, Wen
    [J]. FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [10] BAFF (B-cell activating factor) expression in IgG4-related disease
    Pizzimenti, S.
    Viglino, F.
    Boita, M.
    Heffler, E.
    Novero, D.
    Bucca, C.
    Rolla, G.
    [J]. ALLERGY, 2015, 70 : 563 - 563
12345